3rd Quarter - Report

TREMONT STRATEGIES GROUP LLC for AMAG PHARMACEUTICAL

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmaceutical issues; access to women's health pharmaceutical products.

Foreign entity interest: COVIS Pharma GmbH, identified in a previous filing, holds the intellectual property underlying AMAG Pharmaceuticals' work and would benefit from AMAG's success in ensuring public access to its product.

LobbyistCovered position, as disclosed
LIESL GREBENSTEIN SHEEHAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Pharmaceutical issues; access to women's health pharmaceutical products.

Foreign entity interest: COVIS Pharma GmbH, identified in a previous filing, holds the intellectual property underlying AMAG Pharmaceuticals' work and would benefit from AMAG's success in ensuring public access to its product.

LobbyistCovered position, as disclosed
LIESL GREBENSTEIN SHEEHAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.